This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Metabolic & Atherosclerosis Research Center. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Clapton S Dias - Innovator in Cholesterol Treatment
Introduction
Clapton S Dias is an inventor based in Newbury Park, CA (US). He is currently associated with Amgen Inc., a leading biotechnology company. Although he has not yet been granted any patents, his work focuses on innovative methods for treating cholesterol-related disorders.
Latest Patent Applications
Clapton S Dias has been involved in several latest patent applications. One of his notable applications is titled "Methods of Treating or Preventing Cholesterol Related Disorders." This invention relates to methods for treating or preventing cholesterol-related disorders, such as hypercholesterolemia, hyperlipidemia, or dyslipidemia, using antibodies against proprotein convertase subtilisin/kexin type 9 (PCSK9). The application also describes formulations and methods for producing these formulations. Another application with the same title further elaborates on these methods and formulations.
Conclusion
Clapton S Dias is making significant contributions to the field of cholesterol treatment through his innovative patent applications. His work at Amgen Inc. highlights the importance of research and development in addressing health-related challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile